Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries
Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries
复制标题
DOI：
10.3332/ecancer.2020.1060
复制
发表时间：
2020-06-17
影响因子：
1.8
通讯作者：
Carvalho, Jesus Paula
中科院分区：
文献类型：
--
作者：
Estevez-Diz, Maria del Pilar;Bonadio, Renata Colombo;Carvalho, Jesus Paula
在COVID-19大流行期间，全球的卫生服务正在进行重要的调整，以帮助感染COVID-19的患者，同时继续为其他可能危及生命的疾病提供援助。尽管癌症患者发生与COVID-19感染相关的严重事件的风险可能会增加，但他们的肿瘤治疗通常不能长时间延迟而不危及肿瘤结局。宫颈癌主要集中在中低收入国家（LMIC），由于许多地方的卫生资源稀缺，这些国家在COVID-19大流行期间面临特殊挑战。虽然宫颈癌是妇女癌症死亡的第四大原因，但它很少受到国际肿瘤学会和科学研究的关注。在这篇综述文件中，我们讨论了宫颈癌的情况，并就COVID-19大流行期间的宫颈癌管理提供了专家建议，特别是针对中低收入国家的现实。
During the COVID-19 pandemic, health services worldwide are going through important adaptations to assist patients infected with COVID-19, at the same time as continuing to provide assistance to other potentially life-threatening diseases. Although patients with cancer may be at increased risk for severe events related to COVID-19 infection, their oncologic treatments frequently cannot be delayed for long periods without jeopardising oncologic outcomes. Considering this, a careful consideration for treatment management of different malignancies is required.Cervical cancer is concentrated mainly in low-middle income countries (LMICs), which face particular challenges during the COVID-19 pandemic due to the scarcity of health resources in many places. Although cervical cancer is the fourth cause of cancer death among women, it receives little attention from international Oncology societies and scientific research studies. In this review paper, we discuss the cervical cancer landscape and provide specialists recommendations for its management during the COVID-19 pandemic, particularly focused on LMICs' reality.